Correction: Cardiorenal effectiveness of empagliflozin vs. glucagon-like peptide-1 receptor agonists: final-year results from the EMPRISE study

Cardiovasc Diabetol. 2024 Mar 18;23(1):103. doi: 10.1186/s12933-024-02190-6.
No abstract available

Publication types

  • Published Erratum